Literature DB >> 24645225

Mortality and reoperations following lower limb amputations.

Noam Rosen, Roy Gigi, Amir Haim, Moshe Salai, Ofir Chechik.   

Abstract

BACKGROUND: Above-the-knee amputations (AKA) and below-the-knee amputations (BKA) are commonly indicated in patients with ischemia, extensive tissue loss, or infection. AKA were previously reported to have better wound-healing rates but poorer rehabilitation rates than BKA.
OBJECTIVES: To compare the outcomes of AKA and BKA and to identify risk factors for poor outcome following leg amputation.
METHODS: This retrospective cohort study comprised 188 consecutive patients (mean age 72 years, range 25-103, 71 males) who underwent 198 amputations (91 AKA, 107 BK 10 bilateral procedures) between February 2007 and May 2010. Included were male and female adults who underwent amputations for ischemic, infected or gangrenotic foot. Excluded were patients whose surgery was performed for other indications (trauma, tumors). Mortality and reoperations (wound debridement or need for conversion to a higher levelof amputation) were evaluated as outcomes. Patient- and surgery-related risk factors were studied in relation to these primary outcomes.
RESULTS: The risk factors for mortality were dementia [hazard ratio (HR) 2.769], non-ambulatory status preoperatively (HR 2.281), heart failure (HR 2.013) and renal failure (HR 1.87). Resistant bacterial infection (HR 3.083) emerged as a risk factor for reoperation. Neither AKA nor BKA was found to be an independent predictor of mortality or reoperation.
CONCLUSIONS: Both AKA and BKA are associated with very high mortality rates. Mortality is most probably related to serious comorbidities (renal and heart disease) and to reduced functional status and dementia. Resistant bacterial infections are associated with high rates of reoperation. The risk factors identified can aid surgeons and patients to better anticipate and possibly prevent severe complications.

Entities:  

Mesh:

Year:  2014        PMID: 24645225

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  7 in total

1.  Preoperative Predictors of 30-Day Mortality and Prolonged Length of Stay after Above-Knee Amputation.

Authors:  Eric S Wise; William G McMaster; Kelly Williamson; Justine E Wergin; Kyle M Hocking; Colleen M Brophy
Journal:  Ann Vasc Surg       Date:  2015-11-23       Impact factor: 1.466

2.  PKCβ increases ROS levels leading to vascular endothelial injury in diabetic foot ulcers.

Authors:  Zhichuan Liu; Ling Hu; Tao Zhang; Hang Xu; Hailin Li; Zhouqian Yang; Mei Zhou; Hendrea Shaniqua Smith; Jing Li; Jianhua Ran; Zhongliang Deng
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

3.  A Series of 210 Peripheral Arterial Disease Below-Knee Amputations and Predictors for Subsequent Above-Knee Amputations.

Authors:  Jing Ting Wu; Maggie Wong; Zhiwen Joseph Lo; Wei-En Wong; Sriram Narayanan; Glenn Wei Leong Tan; Sadhana Chandrasekar
Journal:  Ann Vasc Dis       Date:  2017-09-25

4.  Amputation stump perfusion is predictive of post-operative necrotic eschar formation.

Authors:  Gayan S De Silva; Khalid Saffaf; Luis A Sanchez; Mohamed A Zayed
Journal:  Am J Surg       Date:  2018-05-19       Impact factor: 2.565

Review 5.  Lower extremity reamputation in people with diabetes: a systematic review and meta-analysis.

Authors:  Rongqi Liu; Brian J Petersen; Gary M Rothenberg; David G Armstrong
Journal:  BMJ Open Diabetes Res Care       Date:  2021-06

6.  Progression of disease preceding lower extremity amputation in Denmark: a longitudinal registry study of diagnoses, use of medication and healthcare services 14 years prior to amputation.

Authors:  Pia Søe Jensen; Janne Petersen; Klaus Kirketerp-Møller; Ingrid Poulsen; Ove Andersen
Journal:  BMJ Open       Date:  2017-11-03       Impact factor: 2.692

7.  A predictive score for 30-day survival for patients undergoing major lower limb amputation for peripheral arterial obstructive disease.

Authors:  Marco Franchin; Vincenzo Palermo; Carlo Iannuzzi; Nicola Rivolta; Gaddiel Mozzetta; Matteo Tozzi; Ruth L Bush; Gabriele Piffaretti
Journal:  Updates Surg       Date:  2021-06-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.